Trials / Conditions / Lung Transplant Infection

Lung Transplant Infection

13 registered clinical trials studyying Lung Transplant Infection — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Antimicrobial Therapeutic Drug Monitoring During Lung Transplant Perioperative Phase NCT06583642	Policlinico Hospital	—
Recruiting	Liquid biopsiEs fOr luNg AllogRaft Damage classificatiOn - LEONARDO NCT06679257	Jesper Magnusson	—
Unknown	Molecular vs Conventional Microbiologic Diagnosis for Infections in Lung Transplantation NCT05960383	Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico	—
Active Not Recruiting	AlloSure Lung Assessment and Metagenomics Outcomes Study NCT05050955	CareDx	—
Withdrawn	Evaluation of Tolsura When Used as Prophylaxis After Lung Transplantation NCT04652050	Hong Nguyen	—
Terminated	The Effect of Early Treatment of PC945 on Aspergillus Fumigatus Lung Infection in Lung Transplant Patients. NCT03905447	Pulmocide Ltd	Phase 2
Unknown	Transplantation Using Hepatitis C Positive Donors, A Safety Trial NCT04017338	Jordan Feld	Phase 3
Unknown	Clinical Significance of Community-acquired Respiratory Virus Infection and Longitudinal Analysis of the Lung NCT03545919	Capital Medical University	—
Active Not Recruiting	Lung Transplant HCV, Pilot Study NCT03112044	University Health Network, Toronto	EARLY_Phase 1
Completed	Extracorporeal Photopheresis (ECP) After Lung Transplantation NCT05721079	Medical University of Vienna	N/A
Completed	Inhaled Beclomethasone After Community-Acquired Respiratory Viral Infection in Lung Transplant Recipients NCT02351180	Washington University School of Medicine	Phase 1 / Phase 2
Completed	Preliminary Study of Dornase Alfa to Treat Chest Infections Post Lung Transplant. NCT01952470	The Alfred	Phase 2
Completed	Pharmacokinetic Analysis of Posaconazole in Lung Transplant Recipients NCT01419678	University of Pittsburgh	N/A